Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 311,709 | 43,472 | 0 | 65 | 191 |
| Cost of Goods | 35,961 | 3,190 | N/A | 4 | 149 |
| Gross Profit | 275,748 | 40,282 | N/A | 62 | 42 |
| Operating Expenses | 126,568 | 62,828 | 48,958 | 30,689 | 29,629 |
| Operating Income | 150,141 | -22,356 | -48,958 | -30,624 | -29,438 |
| Interest Expense | 2,782 | 36 | 34 | 27 | 16 |
| Other Income | 2,657 | 3,067 | 2,653 | 363 | -7 |
| Pre-tax Income | 150,016 | -19,325 | -46,339 | -30,287 | -29,460 |
| Income Tax | -13,039 | -1,395 | N/A | -586 | -1,250 |
| Net Income Continuous | 163,055 | -17,930 | -46,339 | -29,702 | -28,210 |
| Net Income | $163,055 | $-17,930 | $-46,339 | $-29,702 | $-28,210 |
| EPS Basic Total Ops | 2.25 | -0.30 | -0.91 | -0.74 | -0.75 |
| EPS Basic Continuous Ops | 2.26 | -0.30 | -0.91 | -0.74 | -0.75 |
| EPS Diluted Total Ops | 2.04 | -0.30 | -0.91 | -0.74 | -0.75 |
| EPS Diluted Continuous Ops | 2.03 | -0.30 | -0.91 | -0.74 | -0.75 |
| EPS Diluted Before Non-Recurring Items | 1.82 | -0.30 | -0.91 | -0.74 | -0.75 |
| EBITDA(a) | $165,526 | $-21,898 | $-48,752 | $-30,415 | $-29,261 |